Acta Virologica
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Key Metrics
Journal Specifications
- PublisherAEPRESS SRO
- LanguageEnglish
- FrequencyQuarterly
- LanguageEnglish
- FrequencyQuarterly
- Publication Start Year1957
- Website URL
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Acta Virologica been publishing? 
The Acta Virologica has been publishing since 1957 till date.
How frequently is the Acta Virologica published?
Acta Virologica is published Quarterly.
Who is the publisher of Acta Virologica?
The publisher of Acta Virologica is AEPRESS SRO.
How can I view the journal metrics of Acta Virologica on editage?
For the Acta Virologica metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Acta Virologica?
The eISSN number is 1336-2305 and pISSN number is 0001-723X for Acta Virologica.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Virus, Central nervous system, Genotype, Agave, Severe acute respiratory syndrome coronavirus, Transcriptome, Sinusitis, Q fever, Nitric oxide, Agave tequilana, Viral rna, Coxsackievirus b3, Hepatitis C virus, Newcastle disease, Hepatitis B virus, Influenza a, Infectious bronchitis virus, H1n1 virus, Gene expression, Vp1 gene.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.